Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers

A Clinical Study to Assess the Effectiveness of the Hyper Glow Serum on Skin Complexion and Hydration

ClinicalTrials.gov ID: NCT07900308

Public ClinicalTrials.gov record NCT07900308. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 12:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This single-group, open-label, virtual clinical trial will evaluate the effectiveness of the Hyper Glow Serum by DIME Beauty on skin complexion and hydration in 35 female participants over 60 days. Participants will apply 3-5 drops of the serum to the face and neck each morning, with assessments conducted via self-reported questionnaires, expert skin grading, and before-and-after photographs at Baseline, Day 14, Day 30, and Day 60. The primary objective is to examine the effect of daily use of the Hyper Glow Serum on overall skin complexion, including texture, evenness, and brightness. The secondary objective is to assess changes in participants' perception of skin hydration, tightness, and youthfulness over the 60-day intervention period.

Study identification

NCT ID
NCT07900308
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Dime Beauty Co.
Industry
Enrollment
35 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2024 (Actual)
Primary completion
May 31, 2024 (Actual)
Completion
May 31, 2024 (Actual)
Last update posted
Oct 28, 2026

2024

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Citruslabs Las Vegas Nevada 89118 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07900308, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07900308 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →